After-Hours Movers 04/26: (EXPE) (AMZN) (CRAY) (JAZZ) (ABAX) Higher; (MDRX) (DGII) (DECK) (CTCT) Lower
Tweet
Share
E-mail
Get Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts-misys (NASDAQ: MDRX) 45% LOWER; reported Q1 EPS of $0.12, $0.12 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $387.82 million. Allscripts-misys sees FY2012 EPS of $0.74-$0.80, versus prior guidance of $1.06-$1.10 and the consensus of $1.09. Allscripts also announced that Bill Davis, Chief Financial Officer, has decided to leave the Company, effective May 18, 2012, to pursue another opportunity with a private company outside of the healthcare industry. The Company also announced that Phil Pead's service as Chairman of the Board, director and officer of the Company terminated yesterday.
Digi International, Inc. (NASDAQ: DGII) 30% LOWER; reported Q2 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $49 million versus the consensus estimate of $52.7 million. Digi International, Inc. sees Q3 2012 EPS of $0.03-$0.10, versus the consensus of $0.07. Digi International, Inc. sees Q3 2012 revenue of $46-$51 million, versus the consensus of $34.5 million. Digi International, Inc. sees FY2012 EPS of $0.26-$0.38, versus the consensus of $0.30. Digi International, Inc. sees FY2012 revenue of $190-$200 million, versus the consensus of $153.3 million.
Expedia (NASDAQ: EXPE) 17% HIGHER; reported Q1 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $816.5 million versus the consensus estimate of $791.46 million.
Deckers Outdoor Corp (NASDAQ: DECK) 16% LOWER; reported Q1 EPS of $0.20, $0.05 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $246.3 million versus the consensus estimate of $246.48 million. Deckers Outdoor Corp sees Q2 2012 EPS of $-0.60, versus the consensus of $-0.39. Sees Q2 revs up 8%.
Amazon.com, Inc. (NASDAQ: AMZN) 13% HIGHER; reported Q1 EPS of $0.28, $0.21 better than the analyst estimate of $0.07. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.9 billion. Sees Q2 sales of $11.90-$13.3 billion, versus the consensus of $12.82 billion. Sees operating loss of $260 to operating profit of $40 million.
Cray, Inc. (NASDAQ: CRAY) 11% HIGHER; reported Q1 EPS of $0.13, $0.10 better than the analyst estimate of $0.03. Revenue for the quarter came in at $112.3 million versus the consensus estimate of $99 million.
Constant Contract, Inc. (NASDAQ: CTCT) 11% LOWER; reported Q1 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $59.41 million. Sees Q2 2012 EPS of $0.14-$0.15, versus the consensus of $0.19. Constant Contract, Inc. sees Q2 2012 revenue of $61.7-$62.0 million, versus the consensus of $61.8 million.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 10.7% HIGHER; signed a definitive agreement to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the United States and United Kingdom, for $650 million in cash(1) and a potential $50 million milestone payable in cash based upon its lead product, Erwina (asparaginase Erwinia chrysanthemi), achieving a specified U.S. net sales target in 2013.
Silicon Motion Tech (NASDAQ: SIMO) 9.6% LOWER; reported Q1 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $64 million versus the consensus estimate of $61.17 million.
Abaxis, Inc. (NASDAQ: ABAX) 9% HIGHER; reported Q4 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $42.72 million versus the consensus estimate of $40.68 million.
Western Digital Corp. (NYSE: WDC) 7.7% LOWER; reported Q3 EPS of $2.52, $0.99 better than the analyst estimate of $1.53. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $2.38 billion.
Synaptics, Inc. (NASDAQ: SYNA) 7% LOWER; reported Q1 EPS of $0.51, $0.02 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $131.7 million versus the consensus estimate of $132.38 million.
Aarons, Inc. (NYSE: AAN) 6.3% HIGHER; reported Q1 EPS of $0.92, $0.31 better than the analyst estimate of $0.61. Revenue for the quarter came in at $589.9 million versus the consensus estimate of $568.29 million. Aarons, Inc. sees Q2 2012 EPS of $0.44-$0.48, versus the consensus of $0.46. Aarons, Inc. sees FY2012 EPS of $1.96-$2.08, versus the consensus of $1.96.
Fusion-io (NYSE: FIO) 6% HIGHER; reported Q3 EPS of ($0.05), versus $0.50 reported last year. Revenue for the quarter came in at $94.2 million, versus $67.3 million reported last year. Sees Q4 revenue essentially flat sequentially. FY revenue growth is now expected to be approximately 75%.
BJ's Restaurants, Inc. (NASDAQ: BJRI) 5.5% LOWER; reported Q1 EPS of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $167.6 million versus the consensus estimate of $168.49 million.
ResMed, Inc. (NYSE: RMD) 5.4% HIGHER; reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
Skyworks Solutions, Inc. (NASDAQ: SWKS) 5.3% HIGHER; reported Q1 EPS of $0.42, $0.02 better than the analyst estimate of $0.40. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $361.14 million.
Clearwire Corporation (NASDAQ: CLWR) 5% HIGHER; reported Q1 EPS of ($0.44), $0.05 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $322.6 million versus the consensus estimate of $315.5 million.
Starbucks Corp (NASDAQ: SBUX) 4.8% LOWER; reported Q2 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.18 billion. Starbucks Corp sees FY2012 EPS of $1.81-$1.84, versus the consensus of $1.86.
Athenahealth, Inc. (NASDAQ: ATHN) 4.4% LOWER; reported Q1 EPS of $0.17, in-line with the analyst estimate of $0.17. Revenue for the quarter came in at $96.6 million versus the consensus estimate of $93.56 million.
Superior Energy Services, Inc. (NYSE: SPN) 4% HIGHER; reported Q1 EPS of $0.55, $0.04 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $966.8 million versus the consensus estimate of $919.77 million. Superior Energy Services, Inc. sees FY2012 EPS of $3.30-$3.60, versus prior guidance of $3.20-$3.60 and the consensus of $3.29.
Informatica Corp (NASDAQ: INFA) 4% LOWER; reported Q1 EPS of $0.35, $0.02 better than the analyst estimate of $0.33. Revenue for the quarter came in at $196 million versus the consensus estimate of $194.01 million.
Coinstar, Inc. (NASDAQ: CSTR) 3.3% LOWER; reported Q1 EPS of $1.39, $0.51 better than the analyst estimate of $0.88. Revenue for the quarter came in at $568.2 million versus the consensus estimate of $538.09 million. Sees Q2 2012 EPS of $1.09-$1.24, versus the consensus of $1.05. Sees Q2 2012 revenue of $525-$550 million, versus the consensus of $544 million. Sees FY2012 EPS of $4.40-$4.80, versus the consensus of $4.74. Sees FY2012 revenue of $2.16-$2.28 billion, versus the consensus of $2.26 billion.
Maxim Integrated Products (NASDAQ: MXIM) 3% HIGHER; reported Q3 EPS of $0.33, $0.05 better than the analyst estimate of $0.28. Revenue for the quarter came in at $571.2 million versus the consensus estimate of $570.83 million. Maxim Integrated Products sees Q4 2012 EPS of $0.37-$0.41, versus the consensus of $0.34. Maxim Integrated Products sees Q4 2012 revenue of $590-$620 million, versus the consensus of $601.89 million.
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) 3% LOWER; reported Q1 EPS of $0.55, $0.11 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $438.7 million versus the consensus estimate of $473.37 million. Vertex Pharmaceuticals, Inc. reaffirmed FY2012 guidance.
Digi International, Inc. (NASDAQ: DGII) 30% LOWER; reported Q2 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $49 million versus the consensus estimate of $52.7 million. Digi International, Inc. sees Q3 2012 EPS of $0.03-$0.10, versus the consensus of $0.07. Digi International, Inc. sees Q3 2012 revenue of $46-$51 million, versus the consensus of $34.5 million. Digi International, Inc. sees FY2012 EPS of $0.26-$0.38, versus the consensus of $0.30. Digi International, Inc. sees FY2012 revenue of $190-$200 million, versus the consensus of $153.3 million.
Expedia (NASDAQ: EXPE) 17% HIGHER; reported Q1 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $816.5 million versus the consensus estimate of $791.46 million.
Deckers Outdoor Corp (NASDAQ: DECK) 16% LOWER; reported Q1 EPS of $0.20, $0.05 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $246.3 million versus the consensus estimate of $246.48 million. Deckers Outdoor Corp sees Q2 2012 EPS of $-0.60, versus the consensus of $-0.39. Sees Q2 revs up 8%.
Amazon.com, Inc. (NASDAQ: AMZN) 13% HIGHER; reported Q1 EPS of $0.28, $0.21 better than the analyst estimate of $0.07. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.9 billion. Sees Q2 sales of $11.90-$13.3 billion, versus the consensus of $12.82 billion. Sees operating loss of $260 to operating profit of $40 million.
Cray, Inc. (NASDAQ: CRAY) 11% HIGHER; reported Q1 EPS of $0.13, $0.10 better than the analyst estimate of $0.03. Revenue for the quarter came in at $112.3 million versus the consensus estimate of $99 million.
Constant Contract, Inc. (NASDAQ: CTCT) 11% LOWER; reported Q1 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $59.41 million. Sees Q2 2012 EPS of $0.14-$0.15, versus the consensus of $0.19. Constant Contract, Inc. sees Q2 2012 revenue of $61.7-$62.0 million, versus the consensus of $61.8 million.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 10.7% HIGHER; signed a definitive agreement to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the United States and United Kingdom, for $650 million in cash(1) and a potential $50 million milestone payable in cash based upon its lead product, Erwina (asparaginase Erwinia chrysanthemi), achieving a specified U.S. net sales target in 2013.
Silicon Motion Tech (NASDAQ: SIMO) 9.6% LOWER; reported Q1 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $64 million versus the consensus estimate of $61.17 million.
Abaxis, Inc. (NASDAQ: ABAX) 9% HIGHER; reported Q4 EPS of $0.21, $0.04 better than the analyst estimate of $0.17. Revenue for the quarter came in at $42.72 million versus the consensus estimate of $40.68 million.
Western Digital Corp. (NYSE: WDC) 7.7% LOWER; reported Q3 EPS of $2.52, $0.99 better than the analyst estimate of $1.53. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $2.38 billion.
Synaptics, Inc. (NASDAQ: SYNA) 7% LOWER; reported Q1 EPS of $0.51, $0.02 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $131.7 million versus the consensus estimate of $132.38 million.
Aarons, Inc. (NYSE: AAN) 6.3% HIGHER; reported Q1 EPS of $0.92, $0.31 better than the analyst estimate of $0.61. Revenue for the quarter came in at $589.9 million versus the consensus estimate of $568.29 million. Aarons, Inc. sees Q2 2012 EPS of $0.44-$0.48, versus the consensus of $0.46. Aarons, Inc. sees FY2012 EPS of $1.96-$2.08, versus the consensus of $1.96.
Fusion-io (NYSE: FIO) 6% HIGHER; reported Q3 EPS of ($0.05), versus $0.50 reported last year. Revenue for the quarter came in at $94.2 million, versus $67.3 million reported last year. Sees Q4 revenue essentially flat sequentially. FY revenue growth is now expected to be approximately 75%.
BJ's Restaurants, Inc. (NASDAQ: BJRI) 5.5% LOWER; reported Q1 EPS of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $167.6 million versus the consensus estimate of $168.49 million.
ResMed, Inc. (NYSE: RMD) 5.4% HIGHER; reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.
Skyworks Solutions, Inc. (NASDAQ: SWKS) 5.3% HIGHER; reported Q1 EPS of $0.42, $0.02 better than the analyst estimate of $0.40. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $361.14 million.
Clearwire Corporation (NASDAQ: CLWR) 5% HIGHER; reported Q1 EPS of ($0.44), $0.05 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $322.6 million versus the consensus estimate of $315.5 million.
Starbucks Corp (NASDAQ: SBUX) 4.8% LOWER; reported Q2 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.18 billion. Starbucks Corp sees FY2012 EPS of $1.81-$1.84, versus the consensus of $1.86.
Athenahealth, Inc. (NASDAQ: ATHN) 4.4% LOWER; reported Q1 EPS of $0.17, in-line with the analyst estimate of $0.17. Revenue for the quarter came in at $96.6 million versus the consensus estimate of $93.56 million.
Superior Energy Services, Inc. (NYSE: SPN) 4% HIGHER; reported Q1 EPS of $0.55, $0.04 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $966.8 million versus the consensus estimate of $919.77 million. Superior Energy Services, Inc. sees FY2012 EPS of $3.30-$3.60, versus prior guidance of $3.20-$3.60 and the consensus of $3.29.
Informatica Corp (NASDAQ: INFA) 4% LOWER; reported Q1 EPS of $0.35, $0.02 better than the analyst estimate of $0.33. Revenue for the quarter came in at $196 million versus the consensus estimate of $194.01 million.
Coinstar, Inc. (NASDAQ: CSTR) 3.3% LOWER; reported Q1 EPS of $1.39, $0.51 better than the analyst estimate of $0.88. Revenue for the quarter came in at $568.2 million versus the consensus estimate of $538.09 million. Sees Q2 2012 EPS of $1.09-$1.24, versus the consensus of $1.05. Sees Q2 2012 revenue of $525-$550 million, versus the consensus of $544 million. Sees FY2012 EPS of $4.40-$4.80, versus the consensus of $4.74. Sees FY2012 revenue of $2.16-$2.28 billion, versus the consensus of $2.26 billion.
Maxim Integrated Products (NASDAQ: MXIM) 3% HIGHER; reported Q3 EPS of $0.33, $0.05 better than the analyst estimate of $0.28. Revenue for the quarter came in at $571.2 million versus the consensus estimate of $570.83 million. Maxim Integrated Products sees Q4 2012 EPS of $0.37-$0.41, versus the consensus of $0.34. Maxim Integrated Products sees Q4 2012 revenue of $590-$620 million, versus the consensus of $601.89 million.
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) 3% LOWER; reported Q1 EPS of $0.55, $0.11 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $438.7 million versus the consensus estimate of $473.37 million. Vertex Pharmaceuticals, Inc. reaffirmed FY2012 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- Farm equipment maker seen topping forecasts as commodity trends improve
- Bernstein sees 'an entry point in our top-pick' chemical stock
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
